Paclitaxel as a component of initial chemotherapy of advanced ovarian cancer: is the controversy resolved Maurie Markman EDITORIAL Pages: 1 - 3
Role of vindesine in induction chemotherapy in locally-advanced non-small-cell lung cancer Jürgen R. FischerPeter Drings REVIEW Pages: 4 - 9
In vivo influence of p53 status on proliferation and chemoradiosensitivity in non-small-cell lung cancer Jose Antonio PerdomoYoshio NaomotoNoriaki Tanaka ORIGINAL PAPER Pages: 10 - 18
Preclinical evaluation of 9-chloro-2-methylellipticinium acetate alone and in combination with conventional anticancer drugs for the treatment of human brain tumor xenografts Francisco ArguelloMark A. AlexanderEdward A. Sausville ORIGINAL PAPER Pages: 19 - 26
Elevated activity of N -acetylglucosaminyltransferase V in human hepatocellular carcinoma Min YaoDa-Peng ZhouJian-Xin Gu ORIGINAL PAPER Pages: 27 - 30
Do metallothioneins affect the response to treatment in testis cancers? Hanna EidLajos GécziMihály Bak ORIGINAL PAPER Pages: 31 - 36
cis-Diamminedichloroplatinum(II) given in low-dose continuous infusion with concurrent radiotherapy to patients affected by inoperable lung carcinoma: a pharmacokinetic approach Franca MorazzoniCarmen CanevaliAmedeo Vittorio Bedini ORIGINAL PAPER Pages: 37 - 43
Results of iliac crest biopsies taken from 1465 patients with primary breast cancer E.-F. SolomayerI. J. DielG. Bastert ORIGINAL PAPER Pages: 44 - 48
Assessment of the proliferation index in gastric carcinomas with the monoclonal antibody MIB 1 R. BrollC. MahlkeM. W. Strik ORIGINAL PAPER Pages: 49 - 54
Fotemustine and interferon α2b in metastatic malignant melanoma Michael WeichenthalPeter MohrEckhard W. Breitbart ORIGINAL PAPER Pages: 55 - 59
Cathepsins B, H, L and cysteine proteinase inhibitors in renal cell carcinoma: no evidence for dysregulated proteolytic balance Klaus JungBeate FriedrichStefan A. Loening LETTER TO THE EDITORS Pages: 60 - 61